Replies to post #81 on Ambrx Biopharma Inc (AMAM)

[Hercules1]

most definitely:

AMAM has become an attractive buyout candidate with this breakthrough cancer drug.

and they have a strong pipeline also.


large pharma could pick them up or partner with them.